Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jul 16, 2023
Date Accepted: Jul 17, 2023

The final, peer-reviewed published version of this preprint can be found here:

Authorship Correction: Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial

Oulousian E, Chung SH, Ganni E, Razaghizad A, Zhang G, Avram R, Sharma A

Authorship Correction: Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2023;12:e50893

DOI: 10.2196/50893

PMID: 37995337

PMCID: 10704308

Authorship Correction: Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial

  • Emily Oulousian; 
  • Seok Hoon Chung; 
  • Elie Ganni; 
  • Amir Razaghizad; 
  • Guang Zhang; 
  • Robert Avram; 
  • Abhinav Sharma

ABSTRACT

The COVID-19 pandemic has disrupted the health care system, limiting health care resources such as the availability of health care professionals, patient monitoring, contact tracing, and continuous surveillance. As a result of this significant burden, digital tools have become an important asset in increasing the efficiency of patient care delivery. Digital tools can help support health care institutions by tracking transmission of the virus, aiding in the screening process, and providing telemedicine support. However, digital health tools face challenges associated with barriers to accessibility, efficiency, and privacy-related ethical issues.


 Citation

Please cite as:

Oulousian E, Chung SH, Ganni E, Razaghizad A, Zhang G, Avram R, Sharma A

Authorship Correction: Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2023;12:e50893

DOI: 10.2196/50893

PMID: 37995337

PMCID: 10704308

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.